Mostrando ítems 1-5 de 5
Guix Arnau, Marta (Fecha de defensa: 2017-12-19)
Targeted therapies against the Epidermal Growth Factor Receptor (EGFR) are useful to treat many human cancers such as non-small cell lung cancer, colorectal cancer and head and neck cancer. However, the ...
Cañadas Castillo, Israel (Fecha de defensa: 2013-06-25)
Small cell lung carcinoma (SCLC) is a highly lethal disease due to its chemorefractory nature after first line treatment. The mechanisms to overcome this resistance have remained elusive to tackle up ...
Guardia Valenzuela, Cristina (Fecha de defensa: 2019-12-19)
El cáncer de mama HER2-positivo es un subtipo muy agresivo. El desarrollo de terapias anti-diana HER2, particularmente el anticuerpo monoclonal (Mab) trastuzumab, supuso una mejora significativa en el ...
García Parra, Jetzabel (Fecha de defensa: 2012-06-21)
Breast cancer is the main cause of cancer death in women. Improved treatments, prevention programs and earlier detection are reducing the rate of death; however, there is still a high percentage of ...
Dalmases Massegú, Alba (Fecha de defensa: 2012-06-22)
EGFR is a transmembrane tyrosine kinase receptor from the HER family which, upon ligand stimulation, activates different signaling pathways involved in tumorogenesis. EGFR can be targeted by monoclonal ...